MERCURI, NICOLA BIAGIO
 Distribuzione geografica
Continente #
NA - Nord America 81.918
AS - Asia 13.144
EU - Europa 9.733
Continente sconosciuto - Info sul continente non disponibili 1.959
SA - Sud America 1.810
AF - Africa 235
OC - Oceania 38
Totale 108.837
Nazione #
US - Stati Uniti d'America 81.352
SG - Singapore 6.340
IT - Italia 2.753
CN - Cina 2.407
BR - Brasile 1.483
RU - Federazione Russa 1.346
HK - Hong Kong 1.139
VN - Vietnam 966
DE - Germania 941
IE - Irlanda 908
UA - Ucraina 905
BD - Bangladesh 709
FR - Francia 614
GB - Regno Unito 512
KR - Corea 439
FI - Finlandia 405
SE - Svezia 383
JP - Giappone 365
CA - Canada 301
NL - Olanda 238
PL - Polonia 232
IN - India 183
AR - Argentina 130
ID - Indonesia 113
MX - Messico 113
AT - Austria 89
ES - Italia 87
ZA - Sudafrica 84
TR - Turchia 63
IQ - Iraq 55
BE - Belgio 47
CZ - Repubblica Ceca 44
CO - Colombia 40
EC - Ecuador 38
JM - Giamaica 37
UZ - Uzbekistan 37
PH - Filippine 36
CR - Costa Rica 35
PK - Pakistan 35
EG - Egitto 34
MY - Malesia 34
AU - Australia 33
VE - Venezuela 33
RO - Romania 30
CH - Svizzera 29
CL - Cile 28
MA - Marocco 28
EU - Europa 27
SA - Arabia Saudita 27
KG - Kirghizistan 23
AE - Emirati Arabi Uniti 22
LT - Lituania 22
PY - Paraguay 22
TN - Tunisia 20
DK - Danimarca 17
KE - Kenya 17
AL - Albania 16
GR - Grecia 16
PE - Perù 14
PT - Portogallo 14
IL - Israele 13
JO - Giordania 13
TH - Thailandia 13
UY - Uruguay 13
HN - Honduras 12
NI - Nicaragua 12
NP - Nepal 12
TW - Taiwan 12
HR - Croazia 11
DZ - Algeria 10
IR - Iran 10
KZ - Kazakistan 10
AZ - Azerbaigian 9
ET - Etiopia 9
GE - Georgia 9
GT - Guatemala 9
BO - Bolivia 8
QA - Qatar 8
RS - Serbia 8
SI - Slovenia 8
SV - El Salvador 8
TT - Trinidad e Tobago 8
DO - Repubblica Dominicana 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
BG - Bulgaria 6
HU - Ungheria 6
LB - Libano 6
LV - Lettonia 6
MD - Moldavia 6
NO - Norvegia 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
OM - Oman 5
PS - Palestinian Territory 5
SC - Seychelles 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BB - Barbados 4
EE - Estonia 4
Totale 106.833
Città #
Woodbridge 19.262
Wilmington 19.038
Houston 17.608
Singapore 2.922
Fairfield 2.886
Ashburn 2.292
San Jose 1.895
Ann Arbor 1.553
Chandler 1.370
Seattle 1.147
Hong Kong 1.122
Council Bluffs 1.086
Cambridge 950
Beijing 864
Dublin 809
Jacksonville 763
Rome 730
New York 612
Medford 598
Los Angeles 546
Santa Clara 545
The Dalles 442
Dearborn 351
Ho Chi Minh City 314
Tokyo 311
Lawrence 281
Buffalo 263
Milan 257
Zhengzhou 257
Dallas 253
Lauterbourg 244
Hanoi 230
Moscow 215
Helsinki 179
Menlo Park 169
São Paulo 164
Munich 149
San Diego 140
Kraków 133
North Bergen 131
Chicago 110
Orem 104
London 101
Shanghai 101
Phoenix 98
Colorado Springs 89
Monte Vista 85
Norwalk 84
Brooklyn 81
Montreal 81
Naples 81
Warsaw 81
Nuremberg 78
Toronto 75
Redondo Beach 74
Atlanta 70
Jakarta 69
Boardman 65
Denver 65
Johannesburg 59
Stockholm 59
Frankfurt am Main 56
Guangzhou 54
Redwood City 53
Mountain View 52
Seoul 52
Detroit 51
Chennai 50
San Francisco 48
Boston 47
Nanjing 46
Brussels 45
Mexico City 45
Amsterdam 44
Haiphong 43
Manchester 43
Mülheim 43
Palo Alto 43
Belo Horizonte 42
Verona 42
Da Nang 41
Columbus 39
Lappeenranta 36
Washington 36
Brno 35
Rio de Janeiro 35
Vienna 35
Brasília 34
Elk Grove Village 34
Poplar 33
Hefei 32
Palermo 32
Turin 32
University Park 32
Falls Church 31
Florence 31
Miano 30
Salt Lake City 30
Monte Porzio Catone 28
Bologna 27
Totale 86.353
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 630
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 606
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 587
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 523
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 515
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro 513
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 512
Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusion 510
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 509
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation 506
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 502
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 500
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 499
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 495
Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR 491
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 490
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 487
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release 487
Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice 486
Insulin receptor β-subunit haploinsufficiency impairs hippocampal late-phase LTP and recognition memory 485
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 483
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 482
Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis 480
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 479
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 478
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice 478
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 476
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 474
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy 472
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 471
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 471
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease 471
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 470
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 470
A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation 469
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 469
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 466
Familiar trajectories facilitate the interpretation of physical forces when intercepting a moving target 465
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 463
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 463
Effects of Phenobarbital and Levetiracetam on PR and QTc Intervals in Patients with Post-Stroke Seizure 463
The Blockade of K+-ATP channels has neuroprotective effects in an in vitro model of brain ischemia 463
Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation 462
The role of adiponectin receptors in the regulation of synaptic transmission in the hippocampus 462
Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons 461
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 460
Inhibition of hippocampal plasticity in rats performing contrafreeloading for water under repeated administrations of pramipexole 460
Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS 459
Synaptic plasticity in the basal ganglia: a similar code for physiological and pathological conditions 458
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 458
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 458
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 458
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 457
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 456
Cu/Zn-superoxide dismutase (GLY93-->ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture 455
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 455
Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro 454
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 453
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 453
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals 452
Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia 452
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions 450
Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice 449
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons 448
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 446
A case of cerebral stroke caused by a spontaneous dissection of the internal carotid with rapid resolution 445
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis 444
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 444
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 444
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 444
Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons 443
Over-expression of N-type calcium channels in cortical neurons from a mouse model of Amyotrophic Lateral Sclerosis 442
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 442
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. 441
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 440
Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration 439
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 439
Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate 438
Acid-sensing ion channel 1a is required for mGlu receptor dependent long-term depression in the hippocampus 438
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP 437
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 437
Gamma-hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra 436
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 436
Facial diplegia resembling bilateral Ramsay Hunt Syndrome 436
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study 435
Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action 435
alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu,Zn superoxide dismutase (Gly(93) -> Ala) mutation 433
N-ethyl lidocaine (QX-314) protects striatal neurons against ischemia: an in vitro electrophysiological study 433
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 433
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 433
Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism 433
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 432
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 431
Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/-) -3,4-Methylenedioxymethamphetamine (MDMA-"Ecstasy") 431
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 431
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 430
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 430
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine 429
An electrophysiological analysis of the protective effects of felbamate, lamotrigine, and lidocaine on the functional recovery from in vitro ischemia in rat neocortical slices 428
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 428
Totale 46.455
Categoria #
all - tutte 289.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 289.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.860 0 0 153 129 108 248 398 134 162 289 228 1.011
2022/20233.694 421 297 163 415 299 827 350 278 336 57 143 108
2023/20241.664 162 51 104 53 141 385 116 191 41 112 48 260
2024/20259.865 295 1.665 781 506 233 1.005 551 601 767 853 1.474 1.134
2025/202617.975 1.293 647 1.803 1.510 1.480 646 2.234 2.023 1.807 1.815 1.761 956
2026/20273.192 1.466 1.078 648 0 0 0 0 0 0 0 0 0
Totale 108.837